Package 0078-1077-66

Brand: votrient

Generic: pazopanib hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0078-1077-66
Digits Only 0078107766
Product NDC 0078-1077
Product ID 0078-1077_026e2548-8de0-4776-9802-dd3fff2c2635
Description

120 TABLET, FILM COATED in 1 BOTTLE (0078-1077-66)

Marketing

Marketing Status
Marketed Since 2021-12-13
Brand votrient
Generic pazopanib hydrochloride
Sample Package No

Linked Drug Pages (1)

VOTRIENT ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "026e2548-8de0-4776-9802-dd3fff2c2635", "openfda": {"unii": ["33Y9ANM545"], "rxcui": ["867502", "867506"], "spl_set_id": ["eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET, FILM COATED in 1 BOTTLE (0078-1077-66)", "package_ndc": "0078-1077-66", "marketing_start_date": "20211213"}], "brand_name": "VOTRIENT", "product_id": "0078-1077_026e2548-8de0-4776-9802-dd3fff2c2635", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "0078-1077", "generic_name": "pazopanib hydrochloride", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VOTRIENT", "active_ingredients": [{"name": "PAZOPANIB HYDROCHLORIDE", "strength": "200 mg/1"}], "application_number": "NDA022465", "marketing_category": "NDA", "marketing_start_date": "20160712", "listing_expiration_date": "20261231"}